Biolife Solutions Stock Market Value
| BLFS Stock | USD 22.36 0.13 0.58% |
| Symbol | BioLife |
Is there potential for Health Care Equipment & Supplies market expansion? Will BioLife introduce new products? Factors like these will boost the valuation of BioLife Solutions. Projected growth potential of BioLife fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about BioLife Solutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.4 | Earnings Share (0.38) | Revenue Per Share | Quarterly Revenue Growth 0.312 | Return On Assets |
Investors evaluate BioLife Solutions using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating BioLife Solutions' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause BioLife Solutions' market price to deviate significantly from intrinsic value.
It's important to distinguish between BioLife Solutions' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BioLife Solutions should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BioLife Solutions' market price signifies the transaction level at which participants voluntarily complete trades.
BioLife Solutions 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLife Solutions' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLife Solutions.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in BioLife Solutions on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding BioLife Solutions or generate 0.0% return on investment in BioLife Solutions over 90 days. BioLife Solutions is related to or competes with Kestra Medical, Novocure, Azenta, STAAR Surgical, Phreesia, Pulse Biosciences, and Neogen. BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene ther... More
BioLife Solutions Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLife Solutions' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLife Solutions upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 17.79 | |||
| Value At Risk | (4.11) | |||
| Potential Upside | 3.19 |
BioLife Solutions Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLife Solutions' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLife Solutions' standard deviation. In reality, there are many statistical measures that can use BioLife Solutions historical prices to predict the future BioLife Solutions' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.35) | |||
| Treynor Ratio | (0.14) |
BioLife Solutions February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.13) | |||
| Mean Deviation | 1.78 | |||
| Coefficient Of Variation | (1,285) | |||
| Standard Deviation | 2.55 | |||
| Variance | 6.52 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.35) | |||
| Treynor Ratio | (0.14) | |||
| Maximum Drawdown | 17.79 | |||
| Value At Risk | (4.11) | |||
| Potential Upside | 3.19 | |||
| Skewness | 0.5059 | |||
| Kurtosis | 3.59 |
BioLife Solutions Backtested Returns
BioLife Solutions secures Sharpe Ratio (or Efficiency) of -0.0426, which signifies that the company had a -0.0426 % return per unit of risk over the last 3 months. BioLife Solutions exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioLife Solutions' Mean Deviation of 1.78, standard deviation of 2.55, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.51, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BioLife Solutions will likely underperform. At this point, BioLife Solutions has a negative expected return of -0.11%. Please make sure to confirm BioLife Solutions' information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if BioLife Solutions performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.27 |
Poor predictability
BioLife Solutions has poor predictability. Overlapping area represents the amount of predictability between BioLife Solutions time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLife Solutions price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current BioLife Solutions price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.27 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 1.92 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.